Quick Diagnostics Of New Infectious Coronavirus Diagnostik Cepat dari Penularan Virus Corona
Article Sidebar
Picture in here are illustration from public domain image or provided by the author, as part of their works
Published:
Aug 5, 2020
Keywords:
corona viruses, distress syndrome, epidemiology, infections
Main Article Content
Abstract
The emergence in December 2019 of diseases caused by the new coronavirus (2019-nCoV) posed difficult challenges for healthcare professionals and doctors related to the rapid diagnosis and clinical management of patients with this infection.
Article Details
How to Cite
Murodkhonovich, B. M., & Shahzoda , R. (2020). Quick Diagnostics Of New Infectious Coronavirus. Medicra (Journal of Medical Laboratory Science/Technology), 3(1), 27-29. https://doi.org/10.21070/medicra.v3i1.402
Issue
Section
Articles
References
Erofeeva, M.K., Maksakova, V. L., Shelekhova, S. E., & Pozdnyakova, M. G. (2012). Possibility of using Nazaval Plus for the prevention of acute respiratory infections in children // Infection and immunity. Vol 2012, 1-2. Retrieved from https://cyberleninka.ru/article/n/vozmozhnost-primeneniya-preparata-nazaval-plyus-dlya-profilaktiki-ostryh-respiratornyh-zabolevaniy-u-detey
Omrani, A. S., Saad, M. M., Baig, K., & Bahloul, A., … Albarrak, A. M. (2014). Ribavirin and interferonalfa-2aforsevere Middle East respiratory syndrome ecorona virus infection: aretro spective cohort study. Lancet Infect Dis, 14 (11), 1090-1095. doi: 10.1016/S1473-3099(14)70920-X
Osidak L.V., & Obraztsova E.V. (2012). The effectiveness of the inosine pranobex molecule in therapeutic and pediatric practice. Epidemiology of Infectious Diseases. 2012(4), 26-32. Retrieved from https://epidemiology-journal.ru/en/archive/article/11472
WHO (World Health Organization). (2019). Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: Interim Guidance. Updated 2 January 2019. Retrieved From https://apps.who.int/iris/bitstream/handle/10665/178529/WHO_MERS_Clinical_15.1_eng.pdf?sequence=1&isAllowed=y
Omrani, A. S., Saad, M. M., Baig, K., & Bahloul, A., … Albarrak, A. M. (2014). Ribavirin and interferonalfa-2aforsevere Middle East respiratory syndrome ecorona virus infection: aretro spective cohort study. Lancet Infect Dis, 14 (11), 1090-1095. doi: 10.1016/S1473-3099(14)70920-X
Osidak L.V., & Obraztsova E.V. (2012). The effectiveness of the inosine pranobex molecule in therapeutic and pediatric practice. Epidemiology of Infectious Diseases. 2012(4), 26-32. Retrieved from https://epidemiology-journal.ru/en/archive/article/11472
WHO (World Health Organization). (2019). Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: Interim Guidance. Updated 2 January 2019. Retrieved From https://apps.who.int/iris/bitstream/handle/10665/178529/WHO_MERS_Clinical_15.1_eng.pdf?sequence=1&isAllowed=y